Financhill
Sell
15

CLBT Quote, Financials, Valuation and Earnings

Last price:
$13.31
Seasonality move :
-12.05%
Day range:
$13.36 - $13.95
52-week range:
$11.76 - $20.86
Dividend yield:
0%
P/E ratio:
43.92x
P/S ratio:
7.23x
P/B ratio:
7.51x
Volume:
1.6M
Avg. volume:
2.3M
1-year change:
-27.73%
Market cap:
$3.4B
Revenue:
$475.7M
EPS (TTM):
$0.31

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
CLBT
Cellebrite DI Ltd.
$126.1M $0.14 18.11% 42.69% $23.00
DUOT
Duos Technologies Group, Inc.
$10M -$0.01 584.56% -97.56% $14.00
PCOR
Procore Technologies, Inc.
$340.8M $0.36 13.58% -- $72.56
PLTR
Palantir Technologies, Inc.
$1.3B $0.23 74.07% 233.26% $189.92
WDAY
Workday, Inc.
$2.5B $2.32 12.74% 899.51% $188.86
ZS
Zscaler, Inc.
$798.9M $0.90 22.69% 531.88% $290.27
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
CLBT
Cellebrite DI Ltd.
$13.76 $23.00 $3.4B 43.92x $0.00 0% 7.23x
DUOT
Duos Technologies Group, Inc.
$8.79 $14.00 $179.5M -- $0.00 0% 5.64x
PCOR
Procore Technologies, Inc.
$55.81 $72.56 $8.7B -- $0.00 0% 6.34x
PLTR
Palantir Technologies, Inc.
$135.94 $189.92 $325.1B 214.82x $0.00 0% 77.91x
WDAY
Workday, Inc.
$139.11 $188.86 $36.6B 53.84x $0.00 0% 3.91x
ZS
Zscaler, Inc.
$167.36 $290.27 $26.7B -- $0.00 0% 9.21x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
CLBT
Cellebrite DI Ltd.
4.47% -0.527 0.51% 1.47x
DUOT
Duos Technologies Group, Inc.
8.62% 0.710 3.12% 3.74x
PCOR
Procore Technologies, Inc.
5.9% 1.432 0.7% 1.26x
PLTR
Palantir Technologies, Inc.
3.01% 0.513 0.05% 6.99x
WDAY
Workday, Inc.
32.87% 0.701 8.27% 1.22x
ZS
Zscaler, Inc.
48.06% 1.754 3.47% 1.67x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
CLBT
Cellebrite DI Ltd.
$109.1M $22.4M 18.4% 19.2% 17.38% $78.3M
DUOT
Duos Technologies Group, Inc.
$2.5M -$1.1M -50.42% -78.28% -16.23% -$9.6M
PCOR
Procore Technologies, Inc.
$277.3M -$40.4M -7.69% -8.16% -11.57% $91.5M
PLTR
Palantir Technologies, Inc.
$1.2B $575.4M 25.54% 26.52% 40.9% $764M
WDAY
Workday, Inc.
$1.9B $304M 5.59% 7.91% 12.01% $1.2B
ZS
Zscaler, Inc.
$600.9M -$29.5M -1.29% -2.38% -3.75% $412.6M

Cellebrite DI Ltd. vs. Competitors

  • Which has Higher Returns CLBT or DUOT?

    Duos Technologies Group, Inc. has a net margin of 16.5% compared to Cellebrite DI Ltd.'s net margin of -15.13%. Cellebrite DI Ltd.'s return on equity of 19.2% beat Duos Technologies Group, Inc.'s return on equity of -78.28%.

    Company Gross Margin Earnings Per Share Invested Capital
    CLBT
    Cellebrite DI Ltd.
    84.71% $0.08 $507M
    DUOT
    Duos Technologies Group, Inc.
    36.59% -$0.06 $54.2M
  • What do Analysts Say About CLBT or DUOT?

    Cellebrite DI Ltd. has a consensus price target of $23.00, signalling upside risk potential of 57.46%. On the other hand Duos Technologies Group, Inc. has an analysts' consensus of $14.00 which suggests that it could grow by 59.27%. Given that Duos Technologies Group, Inc. has higher upside potential than Cellebrite DI Ltd., analysts believe Duos Technologies Group, Inc. is more attractive than Cellebrite DI Ltd..

    Company Buy Ratings Hold Ratings Sell Ratings
    CLBT
    Cellebrite DI Ltd.
    5 0 0
    DUOT
    Duos Technologies Group, Inc.
    1 0 0
  • Is CLBT or DUOT More Risky?

    Cellebrite DI Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Duos Technologies Group, Inc. has a beta of 1.006, suggesting its more volatile than the S&P 500 by 0.59499999999999%.

  • Which is a Better Dividend Stock CLBT or DUOT?

    Cellebrite DI Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Duos Technologies Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cellebrite DI Ltd. pays -- of its earnings as a dividend. Duos Technologies Group, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CLBT or DUOT?

    Cellebrite DI Ltd. quarterly revenues are $128.8M, which are larger than Duos Technologies Group, Inc. quarterly revenues of $6.9M. Cellebrite DI Ltd.'s net income of $21.3M is higher than Duos Technologies Group, Inc.'s net income of -$1M. Notably, Cellebrite DI Ltd.'s price-to-earnings ratio is 43.92x while Duos Technologies Group, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cellebrite DI Ltd. is 7.23x versus 5.64x for Duos Technologies Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CLBT
    Cellebrite DI Ltd.
    7.23x 43.92x $128.8M $21.3M
    DUOT
    Duos Technologies Group, Inc.
    5.64x -- $6.9M -$1M
  • Which has Higher Returns CLBT or PCOR?

    Procore Technologies, Inc. has a net margin of 16.5% compared to Cellebrite DI Ltd.'s net margin of -10.77%. Cellebrite DI Ltd.'s return on equity of 19.2% beat Procore Technologies, Inc.'s return on equity of -8.16%.

    Company Gross Margin Earnings Per Share Invested Capital
    CLBT
    Cellebrite DI Ltd.
    84.71% $0.08 $507M
    PCOR
    Procore Technologies, Inc.
    79.44% -$0.25 $1.3B
  • What do Analysts Say About CLBT or PCOR?

    Cellebrite DI Ltd. has a consensus price target of $23.00, signalling upside risk potential of 57.46%. On the other hand Procore Technologies, Inc. has an analysts' consensus of $72.56 which suggests that it could grow by 30.01%. Given that Cellebrite DI Ltd. has higher upside potential than Procore Technologies, Inc., analysts believe Cellebrite DI Ltd. is more attractive than Procore Technologies, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    CLBT
    Cellebrite DI Ltd.
    5 0 0
    PCOR
    Procore Technologies, Inc.
    12 7 0
  • Is CLBT or PCOR More Risky?

    Cellebrite DI Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Procore Technologies, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock CLBT or PCOR?

    Cellebrite DI Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Procore Technologies, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cellebrite DI Ltd. pays -- of its earnings as a dividend. Procore Technologies, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CLBT or PCOR?

    Cellebrite DI Ltd. quarterly revenues are $128.8M, which are smaller than Procore Technologies, Inc. quarterly revenues of $349.1M. Cellebrite DI Ltd.'s net income of $21.3M is higher than Procore Technologies, Inc.'s net income of -$37.6M. Notably, Cellebrite DI Ltd.'s price-to-earnings ratio is 43.92x while Procore Technologies, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cellebrite DI Ltd. is 7.23x versus 6.34x for Procore Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CLBT
    Cellebrite DI Ltd.
    7.23x 43.92x $128.8M $21.3M
    PCOR
    Procore Technologies, Inc.
    6.34x -- $349.1M -$37.6M
  • Which has Higher Returns CLBT or PLTR?

    Palantir Technologies, Inc. has a net margin of 16.5% compared to Cellebrite DI Ltd.'s net margin of 43.48%. Cellebrite DI Ltd.'s return on equity of 19.2% beat Palantir Technologies, Inc.'s return on equity of 26.52%.

    Company Gross Margin Earnings Per Share Invested Capital
    CLBT
    Cellebrite DI Ltd.
    84.71% $0.08 $507M
    PLTR
    Palantir Technologies, Inc.
    84.65% $0.24 $7.7B
  • What do Analysts Say About CLBT or PLTR?

    Cellebrite DI Ltd. has a consensus price target of $23.00, signalling upside risk potential of 57.46%. On the other hand Palantir Technologies, Inc. has an analysts' consensus of $189.92 which suggests that it could grow by 36.73%. Given that Cellebrite DI Ltd. has higher upside potential than Palantir Technologies, Inc., analysts believe Cellebrite DI Ltd. is more attractive than Palantir Technologies, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    CLBT
    Cellebrite DI Ltd.
    5 0 0
    PLTR
    Palantir Technologies, Inc.
    13 11 1
  • Is CLBT or PLTR More Risky?

    Cellebrite DI Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Palantir Technologies, Inc. has a beta of 1.637, suggesting its more volatile than the S&P 500 by 63.665%.

  • Which is a Better Dividend Stock CLBT or PLTR?

    Cellebrite DI Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Palantir Technologies, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cellebrite DI Ltd. pays -- of its earnings as a dividend. Palantir Technologies, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CLBT or PLTR?

    Cellebrite DI Ltd. quarterly revenues are $128.8M, which are smaller than Palantir Technologies, Inc. quarterly revenues of $1.4B. Cellebrite DI Ltd.'s net income of $21.3M is lower than Palantir Technologies, Inc.'s net income of $611.6M. Notably, Cellebrite DI Ltd.'s price-to-earnings ratio is 43.92x while Palantir Technologies, Inc.'s PE ratio is 214.82x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cellebrite DI Ltd. is 7.23x versus 77.91x for Palantir Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CLBT
    Cellebrite DI Ltd.
    7.23x 43.92x $128.8M $21.3M
    PLTR
    Palantir Technologies, Inc.
    77.91x 214.82x $1.4B $611.6M
  • Which has Higher Returns CLBT or WDAY?

    Workday, Inc. has a net margin of 16.5% compared to Cellebrite DI Ltd.'s net margin of 5.73%. Cellebrite DI Ltd.'s return on equity of 19.2% beat Workday, Inc.'s return on equity of 7.91%.

    Company Gross Margin Earnings Per Share Invested Capital
    CLBT
    Cellebrite DI Ltd.
    84.71% $0.08 $507M
    WDAY
    Workday, Inc.
    75.87% $0.55 $11.6B
  • What do Analysts Say About CLBT or WDAY?

    Cellebrite DI Ltd. has a consensus price target of $23.00, signalling upside risk potential of 57.46%. On the other hand Workday, Inc. has an analysts' consensus of $188.86 which suggests that it could grow by 35.76%. Given that Cellebrite DI Ltd. has higher upside potential than Workday, Inc., analysts believe Cellebrite DI Ltd. is more attractive than Workday, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    CLBT
    Cellebrite DI Ltd.
    5 0 0
    WDAY
    Workday, Inc.
    20 16 0
  • Is CLBT or WDAY More Risky?

    Cellebrite DI Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Workday, Inc. has a beta of 1.135, suggesting its more volatile than the S&P 500 by 13.487%.

  • Which is a Better Dividend Stock CLBT or WDAY?

    Cellebrite DI Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Workday, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cellebrite DI Ltd. pays -- of its earnings as a dividend. Workday, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CLBT or WDAY?

    Cellebrite DI Ltd. quarterly revenues are $128.8M, which are smaller than Workday, Inc. quarterly revenues of $2.5B. Cellebrite DI Ltd.'s net income of $21.3M is lower than Workday, Inc.'s net income of $145M. Notably, Cellebrite DI Ltd.'s price-to-earnings ratio is 43.92x while Workday, Inc.'s PE ratio is 53.84x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cellebrite DI Ltd. is 7.23x versus 3.91x for Workday, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CLBT
    Cellebrite DI Ltd.
    7.23x 43.92x $128.8M $21.3M
    WDAY
    Workday, Inc.
    3.91x 53.84x $2.5B $145M
  • Which has Higher Returns CLBT or ZS?

    Zscaler, Inc. has a net margin of 16.5% compared to Cellebrite DI Ltd.'s net margin of -1.47%. Cellebrite DI Ltd.'s return on equity of 19.2% beat Zscaler, Inc.'s return on equity of -2.38%.

    Company Gross Margin Earnings Per Share Invested Capital
    CLBT
    Cellebrite DI Ltd.
    84.71% $0.08 $507M
    ZS
    Zscaler, Inc.
    76.25% -$0.07 $3.8B
  • What do Analysts Say About CLBT or ZS?

    Cellebrite DI Ltd. has a consensus price target of $23.00, signalling upside risk potential of 57.46%. On the other hand Zscaler, Inc. has an analysts' consensus of $290.27 which suggests that it could grow by 73.44%. Given that Zscaler, Inc. has higher upside potential than Cellebrite DI Ltd., analysts believe Zscaler, Inc. is more attractive than Cellebrite DI Ltd..

    Company Buy Ratings Hold Ratings Sell Ratings
    CLBT
    Cellebrite DI Ltd.
    5 0 0
    ZS
    Zscaler, Inc.
    32 9 0
  • Is CLBT or ZS More Risky?

    Cellebrite DI Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Zscaler, Inc. has a beta of 1.023, suggesting its more volatile than the S&P 500 by 2.284%.

  • Which is a Better Dividend Stock CLBT or ZS?

    Cellebrite DI Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Zscaler, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cellebrite DI Ltd. pays -- of its earnings as a dividend. Zscaler, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CLBT or ZS?

    Cellebrite DI Ltd. quarterly revenues are $128.8M, which are smaller than Zscaler, Inc. quarterly revenues of $788.1M. Cellebrite DI Ltd.'s net income of $21.3M is higher than Zscaler, Inc.'s net income of -$11.6M. Notably, Cellebrite DI Ltd.'s price-to-earnings ratio is 43.92x while Zscaler, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cellebrite DI Ltd. is 7.23x versus 9.21x for Zscaler, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CLBT
    Cellebrite DI Ltd.
    7.23x 43.92x $128.8M $21.3M
    ZS
    Zscaler, Inc.
    9.21x -- $788.1M -$11.6M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Sell
50
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 38x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Sell
37
Is GOOGL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Buy
59
SEZL alert for Feb 27

Sezzle, Inc. [SEZL] is down 15.01% over the past day.

Buy
83
GCT alert for Feb 27

GigaCloud Technology, Inc. [GCT] is down 7.02% over the past day.

Buy
62
LMAT alert for Feb 27

LeMaitre Vascular, Inc. [LMAT] is down 5.48% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock